YANTAI, China--(BUSINESS WIRE)--Bohai Pharmaceuticals Group, Inc. (OTCBB/OTCQB: BOPH), a China-based pharmaceutical company engaged in the production, manufacturing and distribution of Traditional Chinese Medicine (TCM) in China, announced that it has concluded a productive non-deal U.S. road show that it undertook over the past two weeks, visiting various institutions, investment banks and prospective investors throughout the United States.
